The U.S. Meals and Drug Administration (FDA) authorized Poherdy (pertuzumab-dpzb) as the primary interchangeable biosimilar to Perjeta (pertuzumab) for sufferers with HER2-positive...
The U.S. Meals and Drug Administration (FDA) has granted orphan drug designation to tinostamustine, an investigational therapeutic from Purdue Pharma L.P., for...
Dr. Joshua Sabari, an assistant professor within the Division of Medication at NYU Grossman College of Medication and director of Excessive Reliability...
